Short answer
After STI treatment, the follow-up test depends on the infection and the reason for testing. CDC recommends retesting about 3 months after diagnosis or treatment for chlamydia, gonorrhea, and trichomoniasis in women because reinfection is common. That is different from a test of cure, which is an earlier repeat test used in selected situations to confirm treatment worked.
Retesting versus test of cure
| Term | What it means | Common timing |
|---|---|---|
| Retesting for reinfection | A repeat test after treatment to see whether infection has returned or a new exposure caused reinfection. | Often about 3 months for chlamydia, gonorrhea, and trichomoniasis in women. |
| Test of cure | A repeat test used to document that treatment cleared the infection. | Earlier and infection-specific, such as about 4 weeks for chlamydia during pregnancy or 7 to 14 days for pharyngeal gonorrhea. |
| Symptom follow-up | Evaluation when symptoms persist, recur, or worsen after treatment. | As soon as symptoms raise concern; do not wait for a routine 3-month retest. |
| Syphilis serologic follow-up | Repeat blood titers used to monitor response and possible reinfection or treatment failure. | Depends on stage; early syphilis is commonly followed at 6 and 12 months, while latent syphilis uses 6, 12, and 24 months. |
Common CDC-aligned timelines
| Infection | Typical retesting or follow-up | Important caveat |
|---|---|---|
| Chlamydia | Retest about 3 months after treatment. | CDC does not advise a routine test of cure for nonpregnant people treated with recommended or alternative regimens unless adherence is in question, symptoms persist, or reinfection is suspected. NAAT testing less than 4 weeks after therapy can be falsely positive from nonviable organisms. |
| Chlamydia during pregnancy | Test of cure about 4 weeks after therapy, plus retesting 3 months after treatment. | CDC also describes additional third-trimester or delivery testing for some pregnant people based on risk and prior testing. |
| Gonorrhea | Retest 3 months after treatment. | A test of cure is unnecessary for uncomplicated urogenital or rectal gonorrhea treated with recommended or alternative regimens, but pharyngeal gonorrhea should have a test of cure 7 to 14 days after treatment. |
| Trichomoniasis | Sexually active women should retest about 3 months after initial treatment. | CDC says data are insufficient to support routine retesting of men after treatment. Persistent or recurrent cases need clinician-guided timing and test selection. |
| Syphilis | Follow-up blood testing depends on stage. | CDC describes clinical and serologic evaluation at 6 and 12 months after primary or secondary syphilis treatment, and quantitative nontreponemal tests at 6, 12, and 24 months for latent syphilis. |
| HIV after an STI diagnosis | HIV testing may be recommended at diagnosis or follow-up depending on the STI and risk. | CDC notes that people with syphilis should be tested for HIV at diagnosis and treatment; some should be offered PrEP and retested for HIV in 3 months if the first HIV test is negative. |
Why 3-month retesting matters
Many positive tests after treatment are not because the medicine failed. CDC emphasizes that repeat chlamydia and gonorrhea infections often come from sex partners not receiving treatment or from sex with a new infected partner. A 3-month retest is meant to catch repeat infection early and create another chance to protect partners, fertility, pregnancy, and HIV prevention.
When not to wait 3 months
Do not wait for a routine retest if symptoms persist, return, or worsen; if treatment was not completed; if vomiting or medication problems may have affected treatment; if a partner was not treated; if you had sex before the advised waiting period ended; if you are pregnant; or if you were told the infection was at the throat, rectum, cervix, or another site needing specific follow-up. Those situations can need earlier clinical guidance.
Partner treatment affects retesting
Retesting is not a substitute for partner care. If partners are not treated when needed, reinfection can happen even when the original treatment worked. Ask which partners should be notified, tested, or treated, whether expedited partner therapy is allowed where you live, and when it is safe to resume sex. For partner-care details, see the partner notification and EPT guide.
Questions to ask after treatment
- Do I need routine retesting, a test of cure, or both?
- When should the follow-up test happen for this specific infection and body site?
- Could testing too early create a false-positive result?
- Which partners need testing, treatment, or notification?
- Should I also test for HIV, syphilis, chlamydia, gonorrhea, trichomoniasis, hepatitis B, or hepatitis C?
- Do I need to discuss HIV PrEP, HIV PEP, DoxyPEP, condoms, or vaccines?
Related Lab Intel guides
For what to do right after a positive result, see the positive STI result next steps guide. For partner notification and EPT, see the partner notification and EPT guide. For chlamydia and gonorrhea testing, see the chlamydia and gonorrhea testing guide. For syphilis blood-test patterns, see the syphilis testing guide. For trich panel gaps and retesting, see the trichomoniasis testing guide. For new-exposure timing, see the STI testing after a new partner guide. For prevention options, see the DoxyPEP guide and the PrEP vs PEP testing timelines guide.